Search

Your search keyword '"Geiger, Xochiquetzal J."' showing total 4 results
Start Over Author "Geiger, Xochiquetzal J." Database Supplemental Index
4 results on '"Geiger, Xochiquetzal J."'

1. Impact of PTEN Protein Expression on Benefit From Adjuvant Trastuzumab in Early-Stage Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in the North Central Cancer Treatment Group N9831 Trial.

Author

Perez, Edith A., Dueck, Amylou C., McCullough, Ann E., Beiyun Chen, Geiger, Xochiquetzal J., Jenkins, Robert B., Lingle, Wilma L., Davidson, Nancy E., Martina, Silvana, Kaufman, Peter A., Kutteh, Leila A., Sledge, George W., Harris, Lyndsay N., Gralow, Julie R., and Reinholz, Monica M.

Published
2013
Full Text
View/download PDF

3. Excellent Renal Allograft Survival in Donor-Specific Antibody Positive Transplant Patients—Role of Intravenous Immunoglobulin and Rabbit Antithymocyte Globulin

Author

Mai, Martin L., Ahsan, Nasimul, Wadei, Hani M., Genco, Petrina V., Geiger, Xochiquetzal J., Willingham, Darrin L., Taner, C Burcin, Hewitt, Winston R., Grewal, Hani P., Nguyen, Justin H. H., Hughes, Christopher B., and Gonwa, Thomas A.

Abstract

Timely transplantation of sensitized kidney recipients remains a challenge. Patients with a complement-dependent cytotoxicity negative and flow cytometry (FC) positive crossmatch carry increased risk of antibody-mediated rejection and thus graft loss. Solid phase assays are available to confirm donor specificity for antibody identified by FC crossmatch. Treatment using induction therapy with rabbit antithymocyte globulin (RATG) and intravenous immunoglobulin (IVIG) may allow successful transplant of these high-risk patients.

Published
2009
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results